Abeona Therapeutics (ABEO) Gross Margin (2011 - 2026)

Abeona Therapeutics' Gross Margin history runs 9 years deep, the most recent figure standing at 69.08% for Q1 2026.

• In Q1 2026, Gross Margin changed N/A year-over-year to 69.08%; the TTM figure through Mar 2026 stood at 67.57% (changed N/A YoY), while the FY2025 annual figure was 73.68%, changed N/A from the prior year.
• Gross Margin was 69.08% for Q1 2026 at Abeona Therapeutics, down from 73.58% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 75.0% in Q2 2025 to a low of 47.06% in Q4 2022.
• Historically, Gross Margin has averaged 48.43% across 4 years, with a median of 67.04% in 2022.
• Biggest YoY gain for Gross Margin was 1000 bps in 2023; the steepest drop was 1000 bps in 2023.
• A 4-year view of Gross Margin shows it stood at 47.06% in 2022, then soared by 217 bps to 55.0% in 2023, then surged by 34 bps to 73.58% in 2025, then slipped by 6 bps to 69.08% in 2026.
• The last three Gross Margin figures came in at 69.08% (Q1 2026), 73.58% (Q4 2025), and 75.0% (Q2 2025), per Business Quant data.